查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927725

全球基因检测市场：依疾病类型、技术、最终用户、国家及地区划分－产业分析、市场规模、份额及2025年至2032年未来预测

Hereditary Testing Market, Report Disease Type, By Technology, End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，基因检测市场规模将达到 161.102 亿美元，从 2025 年到 2032 年，年复合成长率将达到 14.01%。

由于遗传疾病盛行率上升、意识提升以及检测技术的进步，全球基因检测市场正经历显着增长。基因检测在遗传风险评估中发挥关键作用，并广泛应用于产前筛检、癌症易感性检测和携带者筛检。次世代定序技术的应用以及基因检测服务可近性的提高是推动已开发地区和新兴地区市场成长的关键因素。

基因检测市场动态

遗传疾病呈上升趋势

囊肿纤维化、镰状贫血症和各种遗传性癌症等遗传性疾病的日益普遍是推动基因检测市场发展的主要因素，因为定期进行基因筛检和监测对于有效的疾病管理、风险评估和患者咨询至关重要。多基因panel检测技术的进步显着提高了诊断的准确性、效率和临床效用，促进了其在常规实践中的广泛应用。医护人员和患者对基因检测在个人化医疗中作用的认识不断提高，进一步推动了市场需求。例如，2024年11月，CeGaT GmbH推出了其改良的EXOME富集产品“ExomeXtra v6”，该产品扩展了对非编码剪接区域和拷贝数变异（CNV）的分析范围，从而能够更精确地诊断包括肿瘤综合征在内的遗传性疾病。此外，实验室自动化、数位健康平台和远端医疗领域的持续创新提高了检测的可近性和周转时间，为市场的持续成长和技术进步提供了支援。

基因检测市场：細項分析

全球基因检测市场按疾病类型、技术、最终用户和地区进行细分。

根据疾病类型，市场可细分为囊肿纤维化、镰状贫血、血友病和其他遗传性疾病。由于囊肿纤维化和镰状细胞贫血症的高发生率以及对早期诊断和治疗日益增长的需求，这两种疾病的检测占据了相当大的市场份额。现有筛检计画的广泛应用以及人们对遗传性疾病认识的提高也是推动市场成长的因素。此外，早期疗育策略和新生儿筛检计画也促进了检测率的提高。

依技术划分，市场可分为次世代定序(NGS)、聚合酵素链锁反应(PCR)、微阵列和其他技术。次世代定序凭藉其在基因检测中提供的高精度和高效率，在业界占据主导地位。它能够同时分析多个基因，从而缩短检测週期并降低成本。临床应用的不断拓展和定序成本的持续下降，进一步推动了下一代定序技术的普及。

根据最终用户，市场可细分为医院、诊断检查室、基因检测中心和其他机构。其中，医院和诊断检查室占据最大份额，能够进行大规模检测，并透过全面的基因服务来支援病患管理。多学科医疗团队和先进的诊断基础设施进一步提升了这些机构在遗传疾病诊断和监测方面的作用。

基因检测市场—区域分析

北美地区在基因检测市场占据领先地位，这主要得益于其先进的医疗基础设施和较高的基因检测普及率。该地区持续的研究活动和有利的报销政策是推动市场成长的主要动力。欧洲紧随其后，其强大的公共卫生体系和日益增强的遗传疾病意识为其发展提供了支持。亚太地区预计将成为成长最快的地区，这主要归功于医疗费用支出的增加、意识提升以及基因检测技术的进步。拉丁美洲和中东及非洲国家预计将保持稳定成长，这得益于医疗保健服务的逐步改善和对基因检测服务需求的不断增长。

基因检测市场—国家分析

美国凭藉庞大的检测量、先进的诊断技术以及许多大型基因检测公司，在基因检测市场占据主导地位。在欧洲，德国、英国和法国等国在完善的医疗保健体系的支持下，大力推动市场成长，这些体系鼓励常规基因检测。在亚洲，中国和印度正迅速崛起为成长最快的市场，这主要得益于其庞大的人口基数、日益增强的遗传健康意识以及不断完善的医疗基础设施。这些因素使得基因检测解决方案更加普及，推动了整个市场的需求。

目录

第一章 基因检测市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章：基因检测市场的主要趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

第四章 基因检测市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

第五章 基因检测市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章 基因检测市场现状

  • 基因检测市场占有率分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章 依疾病类型分類的基因检测市场

  • 概述
    • 细分市场占有率分析：依疾病类型划分
    • 囊肿纤维化
    • 镰状细胞性贫血症
    • 血友病
    • 其他的

第八章 按技术分類的基因检测市场

  • 概述
    • 细分市场占有率分析：依技术划分
    • 次世代定序（NGS）
    • 聚合酵素链锁反应（PCR）
    • 微阵列
    • 其他的

第九章 依最终用户分類的基因检测市场

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 医院
    • 诊断检查室
    • 基因检测中心
    • 其他的

第十章 各地区的基因检测市场

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十一章 主要供应商分析—基因检测产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • Illumina
    • Thermo Fisher Scientific
    • Quest Diagnostics
    • Invitae Corporation
    • Agilent Technologies
    • Myriad Genetics
    • GeneDx
    • Fulgent Genetics
    • Archerdx
    • BGI Group
    • Others

第十二章：分析师视角360度分析

简介目录
Product Code: ANV5962

The Hereditary Testing Market size was valued at US$16,110.20 Million in 2024, expanding at a CAGR of 14.01% from 2025 to 2032.

The global hereditary testing market is witnessing significant growth due to the rising prevalence of genetic disorders, increased public awareness, and advancements in testing technologies. Hereditary testing plays an essential role in assessing genetic risks and is widely utilized for prenatal screening, cancer susceptibility testing, and carrier screening. The integration of next-generation sequencing technologies and the expansion of access to genetic testing services are key factors driving market growth across both developed and emerging regions.

Hereditary Testing Market- Market Dynamics

Rising prevalence of genetic disorders

The rising prevalence of hereditary conditions such as cystic fibrosis, sickle cell disease, and various inherited cancers is a key driver of the hereditary testing market, as regular genetic screening and monitoring are essential for effective disease management, risk assessment, and patient counselling. Advancements in multi-gene panel testing have significantly improved diagnostic accuracy, efficiency, and clinical relevance, supporting broader adoption in routine care. Growing awareness among healthcare professionals and patients about the role of genetic testing in personalised medicine is further accelerating demand. For instance, in November 2024, CeGaT GmbH launched the enhanced ExomeXtra v6 exome enrichment product, offering expanded coverage of non-coding splice regions and copy number variations (CNVs) to enable more precise diagnostics for hereditary conditions, including tumour syndromes. Additionally, continuous innovations in laboratory automation, digital health platforms, and telemedicine are improving accessibility and turnaround times, reinforcing sustained market growth and technological advancement.

Hereditary Testing Market- Segmentation Analysis:

The Global Hereditary Testing Market is segmented based on Disease Type, Technology, End User, and Region.

Based on Disease Type, the market is segmented into Cystic Fibrosis, Sickle Cell Disease, Hemophilia, and Other Genetic Disorders. Cystic fibrosis and sickle cell disease testing account for significant shares due to their high prevalence and the increasing demand for early diagnosis and management. The availability of established screening programs and growing awareness of inherited disorders further support market growth. Additionally, early intervention strategies and newborn screening initiatives contribute to higher testing rates.

Based on Technology, the market is categorised into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, and Others. Next-generation sequencing dominates this segment, driven by advancements that offer high accuracy and efficiency in genetic testing. Its ability to analyse multiple genes simultaneously reduces turnaround time and cost per test. Expanding clinical applications and declining sequencing costs further strengthen NGS adoption.

Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, Genetic Testing Centres, and Others. Hospitals and diagnostic laboratories hold the largest share, as they facilitate high volumes of testing and support patient management through comprehensive genetic services. The presence of multidisciplinary care teams and advanced diagnostic infrastructure enhances their role in genetic disease diagnosis and monitoring.

Hereditary Testing Market- Geographical Insights

North America leads the hereditary testing market, driven by its advanced healthcare infrastructure and high adoption rates of genetic testing. This region benefits from ongoing research initiatives and favourable reimbursement policies. Europe follows closely, supported by strong public health systems and increasing awareness of genetic disorders. The Asia-Pacific region is expected to experience the fastest growth, fueled by rising healthcare expenditures, increased public awareness, and developments in genetic testing technology. Countries in Latin America and the Middle East & Africa are displaying steady growth due to gradual improvements in healthcare access and growing demand for genetic testing services.

Hereditary Testing Market- Country Insights

The United States holds a dominant position in the hereditary testing market, primarily due to high testing volumes, advanced diagnostics, and the presence of leading genetic testing companies. In Europe, countries like Germany, the UK, and France significantly contribute to market growth, supported by well-established healthcare systems promoting regular genetic testing. In Asia, China and India are rapidly emerging as high-growth markets, driven by large populations, increasing awareness of genetic health issues, and expanding healthcare infrastructure. This landscape enhances the accessibility and availability of hereditary testing solutions, driving overall market demand.

Hereditary Testing Market- Competitive Landscape:

The hereditary testing market is moderately competitive, featuring key players such as Illumina, Thermo Fisher Scientific, Quest Diagnostics, Invitae Corporation, Agilent Technologies, Myriad Genetics, GeneDx, Fulgent Genetics, ArcherDX, and BGI Group. These companies focus on assay innovation, automation, and expanding their test portfolios to meet growing healthcare demands. Significant investments in next-generation sequencing technologies, streamlined workflows, and integrated solutions are enhancing accuracy and efficiency. Strategic partnerships and geographic expansion are key strategies that enable participants to strengthen their market positions in response to the increasing demand for hereditary testing services, for instance, February 2025: Fulgent Genetics, Inc. partnered with Foundation Medicine, Inc. to introduce two hereditary germline tests FoundationOne Germline and FoundationOne Germline More in the U.S., leveraging Fulgent's advanced technology platform to enhance comprehensive genetic testing capabilities.

Recent Developments:

In November 2024, CeGaT GmbH launched version 6 (v6) of its proprietary ExomeXtra exome enrichment product, enhancing coverage of non-coding splice regions and copy number variations (CNVs). This upgrade supports improved diagnostic accuracy, particularly for hereditary tumour syndromes, by enabling the detection of a broader spectrum of genetic alterations, including rare and complex variants that were previously challenging to identify.

In October 2023 a rural hospital system in North Carolina, in collaboration with Invitae, implemented universal hereditary testing for all breast cancer patients. The initiative achieved a 91.4% testing uptake and identified pathogenic germline variants in 13% of tested patients, leading to changes in clinical management for nearly 70% of cases. This program highlights the effectiveness of integrating hereditary testing into diverse healthcare settings, enhancing patient outcomes while optimising the use of healthcare resources.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEREDITARY TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Illumina
  • Thermo Fisher Scientific
  • Quest Diagnostics
  • Invitae Corporation
  • Agilent Technologies
  • Myriad Genetics
  • GeneDx
  • Fulgent Genetics
  • Archerdx
  • BGI Group
  • Others

GLOBAL HEREDITARY TESTING MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cystic Fibrosis
  • Sickle Cell Disease
  • Hemophilia
  • Others

GLOBAL HEREDITARY TESTING MARKET, BY TECHNOLOGY ANALYSIS, 2019 - 2032

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Others

GLOBAL HEREDITARY TESTING MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Genetic Testing Centers
  • Others

GLOBAL HEREDITARY TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hereditary Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hereditary Testing Market Snippet by Disease Type
    • 2.1.2. Hereditary Testing Market Snippet by Technology
    • 2.1.3. Hereditary Testing Market Snippet by End User
    • 2.1.4. Hereditary Testing Market Snippet by Country
    • 2.1.5. Hereditary Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Hereditary Testing Key Market Trends

  • 3.1. Hereditary Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hereditary Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hereditary Testing Market Opportunities
  • 3.4. Hereditary Testing Market Future Trends

4. Hereditary Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hereditary Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Hereditary Testing Market Landscape

  • 6.1. Hereditary Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hereditary Testing Market - By Disease Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Type, 2024&2032 (%)
    • 7.1.2. Cystic Fibrosis
    • 7.1.3. Sickle Cell Disease
    • 7.1.4. Hemophilia
    • 7.1.5. Others

8. Hereditary Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
    • 8.1.2. Next-Generation Sequencing (NGS)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Microarray
    • 8.1.5. Others

9. Hereditary Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Genetic Testing Centers
    • 9.1.5. Others

10. Hereditary Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Hereditary Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Hereditary Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Hereditary Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Hereditary Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Hereditary Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Hereditary Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Illumina
    • 11.2.2. Thermo Fisher Scientific
    • 11.2.3. Quest Diagnostics
    • 11.2.4. Invitae Corporation
    • 11.2.5. Agilent Technologies
    • 11.2.6. Myriad Genetics
    • 11.2.7. GeneDx
    • 11.2.8. Fulgent Genetics
    • 11.2.9. Archerdx
    • 11.2.10. BGI Group
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us